XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 26, 2020
Sep. 28, 2019
Cash flows from operating activities--    
Net earnings $ 155,457 $ 243,243
Adjustments to reconcile net earnings to net cash provided by operating activities--    
Depreciation and amortization expense 81,594 77,272
Amortization of discount and issuance costs on convertible notes 2,130 0
Non-cash share-based compensation 14,422 3,257
Deferred income taxes 11,696 9,931
Net periodic pension benefit (other than service costs) (30,004) (22,233)
Changes in assets and liabilities, net of acquisitions    
Accounts receivable, net 69,176 (1,116)
Inventories, net 43,188 (65,864)
Prepaid expenses and other assets 16,576 1,903
Accounts payable (28,171) (17,659)
Accrued expenses and other liabilities (19,882) 1,010
Net cash provided by operating activities 316,182 229,744
Cash flows from investing activities--    
Additions to property and equipment (29,776) (33,819)
Proceeds from Sale of Property, Plant, and Equipment 9,381 0
Acquisitions, net of cash acquired (33,144) (238,974)
Net cash (used in) investing activities (53,539) (272,793)
Cash flows from financing activities--    
Proceeds under Credit Facility 2,547,305 444,451
Repayments under Credit Facility 3,217,507 375,188
Proceeds from issuance of convertible notes, net of issuance costs 729,933 0
Premiums paid for capped call (104,650) 0
Net proceeds under international credit facilities 2,033 319
Net repayments under other debt arrangement (34) (175)
Payments of deferred purchase price (3,700) (1,648)
Repurchase of treasury stock (77,244) (6,144)
Payments of Debt Issuance Costs 10,974 0
Net cash (used in) provided by financing activities (134,838) 61,615
Effect of exchange rates on cash and cash equivalents (1,995) (3,086)
Changes in cash and cash equivalents--    
Net (decrease) increase in cash and cash equivalents 125,810 15,480
Cash and cash equivalents at beginning of year 94,500 71,701
Cash and cash equivalents at end of quarter 220,310 87,181
Stock issuance related to acquisition $ 3,706 $ 0